TransMedics (TMDX) Net Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn | 1,055.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,055.00 |
| Dec 31, 2025 | 3,298.00 |
| Sep 30, 2025 | 4,583.00 |
| Jun 30, 2025 | 7,832.00 |
| Mar 31, 2025 | 8,604.00 |
| Dec 31, 2024 | -32,158.00 |
| Sep 30, 2024 | 24,334.00 |
| Jun 30, 2024 | 13,376.00 |
| Mar 31, 2024 | 12,484.00 |
| Dec 31, 2023 | -25,868.00 |
| Sep 30, 2023 | 2,555.00 |
| Jun 30, 2023 | 24,867.00 |
| Mar 31, 2023 | 10,104.00 |
| Dec 31, 2022 | -42,642.00 |
| Sep 30, 2022 | 8,601.00 |
| Jun 30, 2022 | 10,613.00 |
| Mar 31, 2022 | 8,094.00 |
| Dec 31, 2021 | 54,283.00 |
| Sep 30, 2021 | -11,307.00 |
| Jun 30, 2021 | 8,669.00 |
| Mar 31, 2021 | 8,231.00 |